| Price | 6.95p on 14-05-2026 at 07:55:10 |
|---|---|
| Change | 0.00p 0% |
| Buy | 7.10p |
| Sell | 6.80p |
| Last Trade: | Sell 28,801.00 at 6.944p |
| Day's Volume: | 233,248 |
| Last Close: | 6.95p |
| Open: | 6.95p |
| ISIN: | GB00BYV81293 |
| Day's Range | 6.95p - 6.95p |
| 52wk Range: | 2.25p - 12.35p |
| Market Capitalisation: | £74.26m |
| VWAP: | 6.862177p |
| Shares in Issue: | 1.07b |
Sector: Medicine and Biotech
Listed In: FTSE AIM All-Share,
Shield Thera (STX) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Sell* | 28,801 | 6.944p | Ordinary |
08:46:39 - 14-May-26 |
| Sell* | 29,090 | 6.875p | Ordinary |
08:37:01 - 14-May-26 |
| Buy* | 231 | 7.08p | Ordinary |
08:32:08 - 14-May-26 |
| Sell* | 30,000 | 6.875p | Ordinary |
08:27:47 - 14-May-26 |
| Sell* | 10,000 | 6.8668p | Ordinary |
08:26:35 - 14-May-26 |
| Buy* | 5 | 7.08p | Ordinary |
08:26:31 - 14-May-26 |
| Buy* | 1,690 | 7.10p | SI Trade |
08:00:12 - 14-May-26 |
| Sell* | 1,903 | 6.80p | SI Trade |
08:00:12 - 14-May-26 |
| Buy* | 28 | 7.10p | SI Trade |
08:00:12 - 14-May-26 |
| Buy* | 650 | 7.10p | SI Trade |
08:00:12 - 14-May-26 |
Shield Thera (STX) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 5th May 2026 7:00 am | RNS | Grant of Share Options |
| 1st May 2026 7:00 am | RNS | Q1 2026 Trading Update |
| 30th Apr 2026 7:01 am | RNS | Total Voting Rights |
| 27th Apr 2026 7:00 am | RNS | Enrollment in Phase II Clinical Trial for ACCRUFeR |
| 9th Apr 2026 12:30 pm | RNS | Audited results for year ended 31 December 2025 |
| 1st Apr 2026 9:22 am | RNS-R | Publication of Report, Reinforcing FDA Approval |
| 31st Mar 2026 7:03 am | RNS | Total Voting Rights |
| 31st Mar 2026 7:00 am | RNS | EMA approves extension - to include adolescents |
| 3rd Mar 2026 7:00 am | RNS | Chinese NMPA Accepts MAA Submission for ACCRUFeR® |
| 27th Feb 2026 7:00 am | RNS | Total Voting Rights |
